Back to Agenda
Session 5: Hot Topics - Bitesize Updates
Session Chair(s)
Elspeth McIntosh, MBA, RN
Director, Castle Pharmacovigilance Ltd, United Kingdom
The Hot Topics session provides insights in the very latest on discussions in specific Safety areas of interest. Experts will address the latest on topics that are being discussed by the Industry Trade Association (EFPIA - should we be more global?) ?and Regulatory Authorities and will therefore give the audience an insight in the key topics of the moment. The expert speakers that lead these discussions will share information on these key topics, the issues at hand, the progress that is being made and what the audience can expect on these topics for the future. The topics will be of interest to a broad audience and will be of specific value to participants that are not able to attend Industry Association meetings or public meetings with EMA due to limited attendance possibilities.
These are some of the topics that we will cover:
- Transitioning in Transparency
- Risk Management Plans
- EMA Publication of full Periodic PSURs
This session offers a great opportunity to hear about these topics from experts in the field. The audience can expect different exciting presentations that will please the crowd.
Speaker(s)
Helen Fiddes
Head of Patient Safety, UK and Ireland, Bristol-Myers Squibb, United Kingdom
Windsor Framework – Catch Up
Michelle Grimes, MSc
Head, International Pharmacovigilance. GCS&PV, MSD, United Kingdom
ICH E2D Updates
Magnus Ysander, MD
EU & UK QPPV & Head Pharmacovigilance Excellence, AstraZeneca, Sweden
PVEG taskforce - 'Non-Fixed-Dose Combination'
Koen Nauwelaerts, PharmD, PhD, MBA
Regulatory Policy and Innovation Lead, Bayer AG, Belgium
Electronic Products Information Pilot and the New Pharma Legislation
Have an account?
